Allarity Therapeutics Inc (ALLR) Stock Price, Quote & News

Company Profile

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing novel anti-cancer therapeutics for patients with unmet medical needs. The company develops drugs for the personalized treatment of cancer using drug specific companion diagnostics generated by its proprietary drug response predictor technology. Its lead drug candidate includes Stenoparib, a novel dual inhibitor of poly-ADP-ribose polymerase (PARP1/2) that is being evaluated in a phase 2...

Industry: Biotechnology

Sector: Healthcare

Phone: (401) 426-4664

Website: www.allarity.com

Address:

24 School Street, 2nd Floor, Boston, United States

Phaarson Jun. 16 at 7:29 PM

$ALLR

0 · Reply

emilpepemil Jun. 16 at 4:17 PM

$ALLR ...never forget! ☝☝☝ New Small Cell Lung Cancer Trial—Combination Study: Patient enrollment will initiate in Q2-Q3 2025 in this new Phase 2 trial evaluating stenoparib in combination with temozolomide for recurrent small cell lung cancer (SCLC). The trial, fully funded by the U.S. Veterans Administration, will assess the potential of this novel combination to improve outcomes in recurrent SCLC patients with extremely limited therapeutic opportunities. https://www.va.gov/health/

1 · Reply

XInFaMoUzZNaSxX Jun. 16 at 3:59 PM

$ALLR added

0 · Reply

Johnm_ Jun. 16 at 3:52 PM

$ALLR Loading...

0 · Reply

ka1954 Jun. 16 at 3:35 PM

$ALLR fucker, goes down with market friday but doesn't recove riwth market

0 · Reply

MichaelSctock Jun. 16 at 2:22 PM

$ALLR weekly looking like it could be this week or next. HUGE squeeze candidate at these levels.

0 · Reply

123Nick Jun. 16 at 2:15 PM

$ALLR Added ✌🏽 Waiting for a bid!

0 · Reply

Ugly1 Jun. 16 at 1:45 PM

$ALLR looking forward to the day I’m out of this

1 · Reply

JetromaxFranky Jun. 16 at 1:40 PM

$ALLR - trying to fit situation do be a you care? lmao. dd - Short ripping .. https://stockcharts.com/sc3/ui/?s=ALLR

0 · Reply

TradPoof Jun. 16 at 1:40 PM

$ALLR Might push up like $ drug 💰📈

0 · Reply

Allarity Therapeutics Announces Changes to Board of Directors

May 9, 2025, 4:05 PM EDT - 5 weeks ago

Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment

Apr 14, 2025, 9:04 AM EDT - 2 months ago

ALLR Shareholders are Encouraged to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Mar 14, 2025, 4:30 AM EDT - 3 months ago

ALLR Investors Have Opportunity to Join Allarity Therapeutics, Inc. Securities Fraud Investigation with the Schall Law Firm

Mar 13, 2025, 8:30 AM EDT - 3 months ago

Allarity Therapeutics Announces Final Settlement with the U.S. Securities and Exchange Commission

Mar 6, 2025, 8:00 AM EST - 3 months ago

Allarity Therapeutics Announces Phase 2 Trial of Stenoparib in Combination with Temozolomide for Recurrent Small Cell Lung Cancer Fully Funded by the US Veterans Administration

Feb 24, 2025, 8:00 AM EST - 4 months ago

Allarity Therapeutics to Begin Enrollment for New Phase 2 Protocol to Advance Stenoparib Toward FDA Approval in Advanced Ovarian Cancer Patients

Feb 14, 2025, 10:00 AM EST - 4 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation

Feb 13, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Shareholders to Inquire about Securities Investigation

Feb 12, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Connect

Feb 11, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Shareholders to Reach Out

Feb 10, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Stockholders to Inquire about Securities Investigation

Feb 9, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Investors to Learn More About the Investigation

Feb 7, 2025, 10:00 AM EST - 4 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation

Feb 6, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Connect

Feb 6, 2025, 8:00 AM EST - 4 months ago

Allarity Therapeutics Announces Expansion of Phase 2 Clinical Trial to Accelerate Development of Stenoparib in Advanced Ovarian Cancer

Feb 4, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Encourages Allarity Therapeutics, Inc. (ALLR) Investors to Inquire about Securities Investigation

Feb 3, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Investors to Reach Out

Feb 2, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Reach Out

Jan 31, 2025, 10:00 AM EST - 4 months ago

Bronstein, Gewirtz & Grossman, LLC Is Investigating Allarity Therapeutics, Inc. (ALLR) And Encourages Stockholders to Connect

Jan 30, 2025, 8:00 AM EST - 4 months ago

Allarity Therapeutics Announces Filing of Form 8-K Regarding Settlement Agreement in Principle with SEC

Jan 8, 2025, 10:00 AM EST - 5 months ago

Allarity Therapeutics, Inc. (ALLR) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation

Jan 5, 2025, 10:00 AM EST - 5 months ago

Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Allarity Therapeutics, Inc. (ALLR) and Encourages Stockholders to Learn More About the Investigation

Nov 18, 2024, 8:00 AM EST - 7 months ago

Allarity Therapeutics Reports Key Progress in Phase 2 Stenoparib Trial and Strategic Corporate Advancements

Nov 11, 2024, 3:45 PM EST - 7 months ago

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 11, 2024, 11:15 AM EST - 7 months ago

DEADLINE TOMORROW: Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Invited To Reach Out To The Schall Law Firm

Nov 9, 2024, 12:30 PM EST - 7 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Invited To Contact The Schall Law Firm

Nov 8, 2024, 7:00 PM EST - 7 months ago

ALLR Deadline: Rosen Law Firm Urges Allarity Therapeutics, Inc. (NASDAQ: ALLR) Stockholders with Large Losses to Contact the Firm for Information About Their Rights

Nov 8, 2024, 9:45 AM EST - 7 months ago

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Allarity Therapeutics

Nov 7, 2024, 11:00 AM EST - 7 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Should Contact The Schall Law Firm

Nov 6, 2024, 11:00 AM EST - 7 months ago

The Schall Law Firm Encourages Stockholder Participation In A Case Against Allarity Therapeutics, Inc. For Fraud

Nov 4, 2024, 11:00 AM EST - 8 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Help The Schall Law Firm

Nov 2, 2024, 11:00 AM EDT - 8 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Investors With Losses Are Urged To Contact The Schall Law Firm

Oct 29, 2024, 11:00 AM EDT - 8 months ago

The Schall Law Firm Invites Stockholders To Join A Lawsuit Against Allarity Therapeutics, Inc. For Fraud

Oct 27, 2024, 11:00 AM EDT - 8 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Affected Investors Are Urged To Contact The Schall Law Firm

Oct 22, 2024, 8:00 AM EDT - 8 months ago

Allarity Therapeutics to be Granted European Patent for DRP® Companion Diagnostic for Stenoparib

Oct 17, 2024, 11:00 AM EDT - 8 months ago

Allarity Therapeutics Inc Is Being Sued For Violating Securities Laws And Impacted Investors Are Urged To Contact The Schall Law Firm

Oct 10, 2024, 8:00 AM EDT - 8 months ago

Allarity Therapeutics Regains Compliance with NASDAQ Minimum Bid Price Requirement

Phaarson Jun. 16 at 7:29 PM

$ALLR

0 · Reply

emilpepemil Jun. 16 at 4:17 PM

1 · Reply

XInFaMoUzZNaSxX Jun. 16 at 3:59 PM

$ALLR added

0 · Reply

Johnm_ Jun. 16 at 3:52 PM

$ALLR Loading...

0 · Reply

ka1954 Jun. 16 at 3:35 PM

$ALLR fucker, goes down with market friday but doesn't recove riwth market

0 · Reply

MichaelSctock Jun. 16 at 2:22 PM

$ALLR weekly looking like it could be this week or next. HUGE squeeze candidate at these levels.

0 · Reply

123Nick Jun. 16 at 2:15 PM

$ALLR Added ✌🏽 Waiting for a bid!

0 · Reply

Ugly1 Jun. 16 at 1:45 PM

$ALLR looking forward to the day I’m out of this

1 · Reply

JetromaxFranky Jun. 16 at 1:40 PM

$ALLR - trying to fit situation do be a you care? lmao. dd - Short ripping .. https://stockcharts.com/sc3/ui/?s=ALLR

0 · Reply

TradPoof Jun. 16 at 1:40 PM

$ALLR Might push up like $ drug 💰📈

0 · Reply

Wody Jun. 16 at 12:09 PM

$ALLR

0 · Reply

fch0906 Jun. 16 at 9:32 AM

$ALLR what is actually going on with this stock

0 · Reply

Mr_Drawdown Jun. 15 at 3:25 AM

$ALLR 25.4M$ cash | analyst consensus 8$ #swing #undervalued

1 · Reply

ka1954 Jun. 13 at 10:36 PM

$ALLR in this market, even worst stocks can go up 300%+ but ALLR hasn't caught on yet. who decides which stocks go up and which dont.

3 · Reply

myman1956 Jun. 13 at 9:51 PM

$SATS I sold on the pop to buy a little more $SOUN AI since reports that shares going to $12.00 or higher on Monday. I'm going to buy $CLOV Investments since they made profits to raise outlook for 2025 to say going to make 70 million in profits this year. The $3.00 should been support, but the news of the attack on Iran hurt many that was going to hit support today to rebound back up. $ALLR even had support with book value is $1.10 with 27 million in cash had great news this week with 2 upgrades with buy rating that the attack on Iran hurting many companies that should have rebound this week.

0 · Reply

snugmunchkin Jun. 13 at 7:13 PM

$ALLR for a moment I thought it was going to recover

0 · Reply

jkgeorge Jun. 13 at 5:08 PM

$ALLR had a choice to invest in $HOVR or $ALLR a few months back, and I chose $ALLR. Damn!!!

1 · Reply

TripleFAT19 Jun. 13 at 3:07 PM

$ALLR buying at .79

0 · Reply

snugmunchkin Jun. 13 at 3:04 PM

$ALLR On a support level. Can either move back up to 0.90 range. Or possibly go back down to low 70's.

0 · Reply

somaopp Jun. 13 at 2:32 PM

$ALLR The ceo needs to resign and hire someone who can better navigate the markets instead of blaming shorts..

1 · Reply

ka1954 Jun. 13 at 2:30 PM

$ALLR sometimes it's war or famine or pestilence. this stock has always some excuse for underperforming

0 · Reply

somaopp Jun. 13 at 2:01 PM

$ALLR down to the 0.70s today??😭😭

0 · Reply

Market Cap	12.11M
Revenue (ttm)	0.00
Net Income (ttm)	-24.52M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	0.00%
Debt to Equity Ratio	0.07

Volume	270,613
Avg Vol	874,068
Day's Range	N/A - N/A
Shares Out	15.08M
Stochastic %K	15%
Beta	-0.15
Analysts	Hold
Price Target	$6,993.00